Entero Therapeutics, Inc. (ENTO) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 7.53M |
| Enterprise Value | 8.8M |
| P/E Ratio | -0.92 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 83.05 |
| Price/Book Ratio | 1.39 |
| Enterprise/Revenue | 85.75 |
| Enterprise/EBITDA | -1.35 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -127.9 |
| Operating Margin | -76.55 |
| Return On Assets | -0.5 |
| Return On Equity | -0.55 |
| Revenue | 36,251 |
| Revenue/Share | 0.02 |
| Gross Profit | 0 |
| EBITDA | 574,713 |
| Net Income | -6.55M |
| Diluted EPS | -4.16 |
| Total Cash | 1.38M |
| Total Cash/Share | 0.21 |
| Total Debt | 1.81M |
| Total Debt/Equity | 0.1 |
| Current Ratio | 0.16 |
| Book Value Per Share | 3.6 |
| 52-Week Change | 92.57 |
| 52-Week High | 5.84 |
| 52-Week Low | 0.97 |
| Moving Average 50 Days | 4.07 |
| Moving Average 200 Days | 2.24 |
| Average Volume | 216,273 |
| Shares Outstanding | 4.77M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0.01 |
| Last Split Factor | 1:3 |
| Last Split Date | August 18, 2025 |